News

US National Cancer Institute Center for Global Health survey on clinical trials in low-and middle-income countries

25 Oct 2023
US National Cancer Institute Center for Global Health survey on clinical trials in low-and middle-income countries

The National Cancer Institute’s (NCI) Center for Global Health (CGH) is initiating a survey to help us gain a better understanding of the current landscape of cancer therapeutic clinical trials in low-and middle-income countries (LMICs), as defined by the World Bank, and learn about clinicians’ thoughts and opinions regarding concrete steps that might be taken to advance clinical trials in LMICs. 

We are seeking clinicians with experience participating as a member of a research team in at least one cancer therapeutic clinical trial with at least one recruitment site or facility in an LMIC to participate in a brief, 15-minute survey.

Responses will help inform a strategic priority for CGH.

The survey is anonymous and voluntary. 

If published, the results will be presented in an aggregated, de-identified format.

There is no compensation for survey completion. 

Source: AORTIC